Conclusions
More than one third of patients in BALKAN-AF received a rhythm control
strategy, and these patients tended to be younger with less
comorbidities than those managed with rate control. EHRA symptom score
is not significantly associated with rhythm control. The most commonly
used antiarrhythmic agents were amiodarone, followed by propafenone.